A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 2113078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
X-linked immunodeficient (xid) (CBA/N female x DBA/2 male) F1 male mice, when treated with cyclophosphamide, were much more susceptible to challenge with aerosolized Pseudomonas aeruginosa serotype 11 than were control F1 female littermates. Mortality of F1 males was decreased significantly after intravenous administration of human P. aeruginosa serotype 11 O-specific monoclonal antibody. Antibody treatment reduced bacterial titers in the lungs as well as the severity of Pseudomonas-induced lung histopathology.
Medical subject headings
- Antibodies, Monoclonal
- Immunization, Passive
- Pneumonia
- Pseudomonas Infections
- Pseudomonas aeruginosa